• Profile
Close

Incidence and mortality of multiple myeloma in China, 2006–2016: An analysis of the Global Burden of Disease Study 2016

Journal of Hematology & Oncology Dec 18, 2019

Liu J, Liu W, Mi L, et al. - Researchers sought to determine the burden of multiple myeloma (MM) at national and provincial level in China via following the general analytical strategy used in Global Burden of Disease 2016, the age-, gender-, and province-specific incidence and mortality. As per estimates, 16,500 new cases and 10,300 deaths of multiple myeloma were reported in China in 2016. The age-standardized incidence rates and mortality rates per 100,000 population were 1.03 and 0.67, respectively. Relative to females, males had higher incidence and mortality rates in all age groups. With age, they observed an upward trend in incidence and mortality. The developed provinces showed the clustering of higher incidence and mortality rates. From 2006 to 2016, a significant increase in the incidence of MM in China was noted, while there was an increase in the mortality from 2006 to 2014, which remained stable from 2014 to 2016. These findings suggest the necessity of tailored disease prevention and control strategies at both national and provincial levels.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay